Mark Engel

Mark Engel

Founder at Excel PharmaStudies, Inc.

Health Technology
Commercial Services

Profile

Mark Engel is the founder of Excel PharmaStudies, Inc. He is currently the Chief Executive Officer & Director at Phagelux, Inc., the Chairman & Chief Executive Officer at Precisio Biotix Therapeutics, Inc., and the Chairman at Phagelux (Canada), Inc.

Mark Engel active positions

CompaniesPositionStart
Founder -
Chief Executive Officer -
Chairman 11/03/2015
All active positions of Mark Engel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Engel's experience

Connections

8

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies3

Commercial Services

Health Technology

Health Technology

See company connections